Concord Drugs

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE858L01010
  • NSEID:
  • BSEID: 538965
INR
68.51
-1.28 (-1.83%)
BSENSE

Nov 20

BSE+NSE Vol: 1.23 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryConcord Drugs VS Pharmaceuticals & Biotechnology
 
1D
-1.83%
1.08%
1W
-4.42%
2.85%
1M
0.75%
13.63%
YTD
-16.94%
-1.53%
1Y
-15.78%
-2%
3Y
102.69%
27.82%
5Y
123.89%
40.72%
10Y
33.68%
220.91%
  • Stock Absolute Returns
  • Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-3.52%
0%
-3.52%
6 Months
-15.16%
0%
-15.16%
1 Year
-15.78%
0%
-15.78%
2 Years
87.75%
0%
87.75%
3 Years
102.69%
0%
102.69%
4 Years
109.83%
0%
109.83%
5 Years
123.89%
0%
123.89%

Concord Drugs for the last several years.

stock-summaryReturn Quartiles
What is a Quartile?

Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.


Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on

Return Quartiles - by Closest Peers stock-summary
Icon
Not enough Stock Price history for Quartile Analysis
Return Quartiles - by Industry stock-summary
Icon
Not enough Stock Price history for Quartile Analysis
Return Quartiles - by Market Cap stock-summary
Icon
Not enough Stock Price history for Quartile Analysis
stock-summaryRisk Adjusted Returns v/s
Risk Adjusted Returns v/s stock-summary
stock-summaryReturns Beta
Returns Beta
Icon
Beta has not been calculated since enough price history is not available